Maternal and Child Health
TABLE OF CONTENTS
Volume 81, Issue 4 (April 2007)
Editorial |
News and Views |
Perspectives |
State of the Art |
Research |
Discovery & Development |
Regulation & Use |
Corrigendum
Contents
Contents
In this issue
Clin Pharmacol Ther 81: 461; doi:10.1038/sj.clpt.6100143
See also: Article by Bailey et al. See also: Article by Blake et al. See also: Article by Hamberg et al. See also: Article by Verheul et al. See also: Article by Yang et al. See also: Translational Medicine by Leeder & MitchellEditorial
Editorial
Clinical Pharmacology: A Discipline Called to Action for Maternal and Child Health
G L Kearns, W A Ritschel, J T Wilson and S P Spielberg
Clin Pharmacol Ther 81: 463-468; doi:10.1038/sj.clpt.6100145
News and Views
Highlights
Highlights
Clin Pharmacol Ther 81: 470-471; doi:10.1038/sj.clpt.6100158
ASCPT News
ASCPT News
Clin Pharmacol Ther 81: 472-473; doi:10.1038/sj.clpt.6100137
Books
Minor Illness or Major Disease? The Clinical Pharmacist in the Community, 4th edn.
M D Reed
Clin Pharmacol Ther 81: 474-475; doi:10.1038/sj.clpt.6100132
Macroscopy
Future of Pediatric Therapeutics: Reauthorization of BPCA and PREA
R M Ward and R Kauffman
Clin Pharmacol Ther 81: 477-479; doi:10.1038/sj.clpt.6100109
Perspectives
Commentaries
"To Care": A Visual Inspiration for Maternal and Child Health
W A Ritschel
Clin Pharmacol Ther 81: 480-481; doi:10.1038/sj.clpt.6100110
Obstetric Clinical Pharmacology: Coming of Age
A Zajicek and G P Giacoia
Clin Pharmacol Ther 81: 481-482; doi:10.1038/sj.clpt.6100136
See also: Article by Andrew et al.State of the Art
State of the Art
Considerations in the Rational Design and Conduct of Phase I/II Pediatric Clinical Trials: Avoiding the Problems and Pitfalls
S M Abdel-Rahman, M D Reed, T G Wells and G L Kearns
Clin Pharmacol Ther 81: 483-494; advance online publication, February 28, 2007; doi:10.1038/sj.clpt.6100134
Research
Articles
Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice
D G Bailey, G K Dresser, B F Leake and R B Kim
Clin Pharmacol Ther 81: 495-502; advance online publication, February 14, 2007; doi:10.1038/sj.clpt.6100104
The Effects of Tadalafil on Cold-induced Vasoconstriction in Patients with Raynaud's Phenomenon
E A Friedman, P A Harris, A J J Wood, C M Stein and D Kurnik
Clin Pharmacol Ther 81: 503-509; advance online publication, February 14, 2007; doi:10.1038/sj.clpt.6100103
Ontogeny of Dextromethorphan O- and N-demethylation in the First Year of Life
M J Blake, A Gaedigk, R E Pearce, L R Bomgaars, M L Christensen, C Stowe, L P James, J T Wilson, G L Kearns and J S Leeder
Clin Pharmacol Ther 81: 510-516; advance online publication, February 14, 2007; doi:10.1038/sj.clpt.6100101
Age-dependent Pharmacokinetics of Lamivudine in HIV-infected Children
D M Burger, G Verweel, N Rakhmanina, C P W G M Verwey-Van Wissen, C J L La Porte, A S Bergshoeff, H Lyall, N G Hartwig, H Green, S Soldin, D M Gibb and R de Groot
Clin Pharmacol Ther 81: 517-520; advance online publication, February 28, 2007; doi:10.1038/sj.clpt.6100118
Pharmacogenomics-based Tailored Versus Standard Therapeutic Regimen for Eradication of H. pylori
T Furuta, N Shirai, M Kodaira, M Sugimoto, A Nogaki, S Kuriyama, M Iwaizumi, M Yamade, I Terakawa, K Ohashi, T Ishizaki and A Hishida
Clin Pharmacol Ther 81: 521-528; advance online publication, January 10, 2007; doi:10.1038/sj.clpt.6100043
A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy
A-K Hamberg, M-L Dahl, M Barban, M G Scordo, M Wadelius, V Pengo, R Padrini and E N Jonsson
Clin Pharmacol Ther 81: 529-538; advance online publication, February 14, 2007; doi:10.1038/sj.clpt.6100084
Genetic Polymorphisms in the ABCB1 Gene and the Effects of Fentanyl in Koreans
H-J Park, H K Shinn, S H Ryu, H-S Lee, C-S Park and J-H Kang
Clin Pharmacol Ther 81: 539-546; advance online publication, December 27, 2006; doi:10.1038/sj.clpt.6100046
Amoxicillin Pharmacokinetics in Pregnant Women: Modeling and Simulations of Dosage Strategies
M A Andrew, T R Easterling, D B Carr, D Shen, M L Buchanan, T Rutherford, R Bennett, P Vicini and M F Hebert
Clin Pharmacol Ther 81: 547-556; advance online publication, February 28, 2007; doi:10.1038/sj.clpt.6100126
Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV-infected Individuals
M Rotger, H Tegude, S Colombo, M Cavassini, H Furrer, L Décosterd, J Blievernicht, T Saussele, H F Günthard, M Schwab, M Eichelbaum, A Telenti and U M Zanger
Clin Pharmacol Ther 81: 557-566; advance online publication, January 18, 2007; doi:10.1038/sj.clpt.6100072
Developmental Changes of Aldehyde Oxidase Activity in Young Japanese Children
Y Tayama, K Miyake, K Sugihara, S Kitamura, M Kobayashi, S Morita, S Ohta and K Kihira
Clin Pharmacol Ther 81: 567-572; doi:10.1038/sj.clpt.6100078
Pharmacokinetic Parameters of Sulfated Tibolone Metabolites in Postmenopausal Women after Single and Multiple Doses of Tibolone
H A M Verheul, C J Timmer and H J Kloosterboer
Clin Pharmacol Ther 81: 573-579; advance online publication, February 14, 2007; doi:10.1038/sj.clpt.6100094
Effect of Rosiglitazone on Visfatin and Retinol-Binding Protein-4 Plasma Concentrations in HIV-Positive Patients
D G Haider, K Schindler, F Mittermayer, M Müller, P Nowotny, A Rieger, A Luger, B Ludvik and M Wolzt
Clin Pharmacol Ther 81: 580-585; advance online publication, January 18, 2007; doi:10.1038/sj.clpt.6100047
Risk of Extrapyramidal Syndrome in Schizophrenic Patients Treated with Antipsychotics: A Population-based Study
S-Y Yang, Y-H Kao Yang, M-Y Chong, Y-H Yang, W-H Chang and C-S Lai
Clin Pharmacol Ther 81: 586-594; advance online publication, January 18, 2007; doi:10.1038/sj.clpt.6100069
Discovery & Development
Translational Medicine
Application of Pharmacogenomic Strategies to the Study of Drug-induced Birth Defects
J S Leeder and A A Mitchell
Clin Pharmacol Ther 81: 595-599; advance online publication, February 21, 2007; doi:10.1038/sj.clpt.6100128
Regulation & Use
Development
Females in Clinical Studies: Where are We Going?
K Uhl, A Parekh and S Kweder
Clin Pharmacol Ther 81: 600-602; advance online publication, February 21, 2007; doi:10.1038/sj.clpt.6100112
World Health Organization Program for the Selection and Use of Essential Medicines
M M Reidenberg
Clin Pharmacol Ther 81: 603-606; advance online publication, February 21, 2007; doi:10.1038/sj.clpt.6100106
Practice
Human Papillomavirus Infection: The Role of Vaccination in Pediatric Patients
J R Nichols, S H Stovall and R F Jacobs
Clin Pharmacol Ther 81: 607-610; advance online publication, February 21, 2007; doi:10.1038/sj.clpt.6100108
Corrigendum
CORRIGENDUM: Effect of Rosiglitazone on Visfatin and Retinol-binding Protein-4 Plasma Concentrations in HIV-positive Patients FREE
D G Haider, K Schindler, F Mittermayer, M Müller, P Nowotny, A Rieger, A Luger, B Ludvik and M Wolzt
Clin Pharmacol Ther 81: 611; doi:10.1038/sj.clpt.6100182
